ARCHIVES

Sharfstein To Leave FDA

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

Coooperative Groops Announce Two Sets of Mergers: NSABP, RTOG Form Alliance; CALGB, NCCTG & ACOSOG Seek to Become Single Group

March 11, 2011

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985

In Brief: Cavenee Is President-elect of AACR; Coffey To Succeed Strong As President

April 11, 1997

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001